Saltar al contenido
Merck
Todas las fotos(3)

Key Documents

View All Documentation

H8901

Sigma-Aldrich

1-Heptanosulfonato de sodio

BioXtra

Sinónimos:

Ácido 1-heptanosulfónico sodium salt

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(3)

About This Item

Fórmula lineal:
C7H15O3SNa
Número de CAS:
22767-50-6
Peso molecular:
202.25
EC Number:
245-210-5
MDL number:
MFCD00007543
UNSPSC Code:
12161900
PubChem Substance ID:
24895834
NACRES:
NA.21

description

anionic

Quality Level

200

product line

BioXtra

mol wt

202.25 g/mol

impurities

<0.001% Phosphorus (P)
<0.1% Insoluble matter

solubility

H2O: 0.5 M at 20 °C, clear, colorless

anion traces

chloride (Cl-): <0.05%

cation traces

Al: <0.0005%
Ca: <0.005%
Cu: <0.0005%
Fe: <0.0005%
K: <0.005%
Mg: <0.0005%
NH4+: <0.05%
Pb: <0.001%
Zn: <0.0005%

SMILES string

[Na+].CCCCCCCS([O-])(=O)=O

InChI

1S/C7H16O3S.Na/c1-2-3-4-5-6-7-11(8,9)10;/h2-7H2,1H3,(H,8,9,10);/q;+1/p-1

InChI key

REFMEZARFCPESH-UHFFFAOYSA-M

¿Está buscando productos similares? Visita Guía de comparación de productos

Application

Reactivo de par iónico para HPLC, incluidos los análisis de péptidos y proteínas.

Storage Class

11 - Combustible Solids

wgk_germany

WGK 2

ppe

Eyeshields, Gloves, type N95 (US)

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
SHBR1516
MKCN2358
MKBX5602V
MKCH7562
MKBR7239V

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Marianna Sikorska et al.
Neurobiology of aging, 35(10), 2329-2346 (2014-04-30)
Although the support for the use of antioxidants, such as coenzyme Q(10) (CoQ(10)), to treat Parkinson's disease (PD) comes from the extensive scientific evidence, the results of conducted thus far clinical trials are inconclusive. It is assumed that the efficacy
Takeshi Oshizaka et al.
International journal of pharmaceutics, 475(1-2), 292-297 (2014-08-27)
Skin concentrations of topically administered compounds need to be considered in order to evaluate their efficacies and toxicities. This study investigated the relationship between the skin permeation and concentrations of compounds, and also predicted the skin concentrations of these compounds
Miriam Dadparvar et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 88(2), 510-517 (2014-07-06)
Severe intoxications with organophosphates require the immediate administration of atropine in combination with acetyl cholinesterase (AChE) reactivators such as HI-6. Although this therapy regimen enables the treatment of peripheral symptoms, the blood-brain barrier (BBB) restricts the access of the hydrophilic
Jie Ma et al.
Pharmacology, 93(5-6), 220-224 (2014-07-12)
It is significant for patients with traumatic brain injury (TBI) to receive prehospital emergency treatment as early as possible to reduce mortality. Therefore, a new prefilled multi-drug injector was developed to improve the treatment of TBI. Here, we studied the
Erina Kitagawa et al.
Bioscience, biotechnology, and biochemistry, 79(8), 1320-1326 (2015-03-18)
We investigated the efficacy of supplementing the diet with pteroylmonoglutamic acid (PGA), choline, or phosphatidylcholine (PC) in ameliorating the lipid accumulation in rat liver that is induced by vitamin B6 (B6) deficiency. In Experiment 1, male Wistar rats were fed
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico